MedPath

海南久常制药有限公司

Ownership
-
Established
2017-05-02
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

48

NMPA:48

Drug Approvals

Fructose for Injection

Product Name
注射用果糖
Approval Number
国药准字H20060387
Approval Date
Aug 16, 2024
NMPA

Aztreonam for Injection

Product Name
注射用氨曲南
Approval Number
国药准字H20063722
Approval Date
Aug 16, 2024
NMPA

Pefloxacin Mesylate for Injection

Product Name
注射用甲磺酸培氟沙星
Approval Number
国药准字H20059982
Approval Date
Aug 16, 2024
NMPA

毛鸡药酒

Approval Number
国药准字Z46020093
Approval Date
Aug 16, 2024
NMPA

Fructose for Injection

Product Name
注射用果糖
Approval Number
国药准字H20060388
Approval Date
Aug 16, 2024
NMPA

Aztreonam for Injection

Product Name
注射用氨曲南
Approval Number
国药准字H20063724
Approval Date
Aug 16, 2024
NMPA

Pefloxacin Mesylate for Injection

Product Name
注射用甲磺酸培氟沙星
Approval Number
国药准字H20059981
Approval Date
Aug 16, 2024
NMPA

Aztreonam for Injection

Product Name
注射用氨曲南
Approval Number
国药准字H20063723
Approval Date
Aug 16, 2024
NMPA

Acetylspiramycin Tablets

Product Name
乙酰螺旋霉素片
Approval Number
国药准字H46020110
Approval Date
Jul 30, 2024
NMPA

Esomeprazole Sodium for Injection

Product Name
注射用艾司奥美拉唑钠
Approval Number
国药准字H20203085
Approval Date
Jul 30, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.